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1. Introduction     
The field of prognostics has grown rapidly in the last decade and clinicians have been 
provided with numerous tools to assist with evidence-based medical decision-making. Most 
of these included nomograms, classification and regression tree analyses, and risk group 
stratification models [Grossberg JA, et al., 2006] and Artificial Neural Networks (ANN) 
[Djavan B, et al., 2002]. Nomograms are graphic representation of statistical model, which 
incorporate multiple continuous variables to predict a patient’s risk of developing a specific 
endpoint (recurrence, survival, complications) [Kattan MW, 2005]. Each variable is assigned 
a scale of points according to its prognostic significance. The total score for all the variables 
is converted to an estimated probability of reaching the endpoint [Akl A, et al., 2008]. 
Statistical approaches require guesses as to how outputs functionally depend on inputs. 
Artificial neural networks have been used for evaluation of clinical data to provide results 
similar to conventional modeling methods [Freeman RV, et al., 2002]. They do not require 
the articulation of such a mathematical model. ANNs are complex computational systems 
that can provide a nonlinear approach for data analysis.  
The ANNs forms a mapping from input to output nodes (simulated neurons) by extracting 
features from input patterns, assigning them weights, summing weights with activation 
functions, and propagating decisions to output nodes if activation thresholds are exceeded. 
Typical networks are organized into three layers of computational units (nodes) in which 
input/output layers are linked by hidden layers of nodes. Subject factors determine the 
number of input units, and the classification complexity determines the number of output 
units. The number of hidden units is determined by trial and error (training). Common 
routines start with one hidden unit and assign small arbitrary weights to all nodal 
connections. The network is fed sample data with known outcomes, and an error term is 
calculated by means of differences between known and predicted outputs. Learning consists 
of adjusting weights by backward pass of errors through the connections to network nodes 
in response to input data. Hidden units are added to achieve minimum error criteria, while 
constraining the number to promote generalization of input patterns and prevent over-
fitting (memorization). Interconnection density determines the network’s ability to correctly 
discriminate the outcomes. In statistical parlance, ANN models are a form of nonlinear 
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discriminant analysis with input units, weights, and activation functions resembling 
covariates, coefficients, and generalized additive models, respectively. To generate an 
accurate prediction model, several conditions should be fulfilled: use of a robust dataset that 
represents a large patient population, and the incorporation of prognostically significant 
variables into the model [Kattan MW, 2005]. In addition, the generated model should be 
validated using an independent testing group [Graefen BM, et al., 2002]. Herein, we have 
developed two predictive models using ANN. The first is to predict graft outcome after 
renal transplantation. The second is to predict patient outcome after radical cystectomy for 
invasive bladder carcinoma. The results of these models were compared with those of 
statistically-based multivariate models. 
2. Artificial intelligence versus Nomogram in renal transplantation: 
The importance of having a possibility to predict the graft outcome after renal 
transplantation does not need emphasis. This would allow the choice of the best possible 
kidney donor and the optimum immunosuppressive therapy for a given patient. Several 
methods have been used to construct a prognostic model. A multivariate analysis was used 
to predict the outcome of renal transplantation from deceased donor in an attempt to 
optimize the allocation of the recovery of organs [Poli F, et al. 2000]. In another study, 
multivariate analysis was used to predict creatinine levels in recipients of kidneys from 
living donors [Zapletal C, et al. 2004]. The probability of deceased donor-graft survival was 
studied using tree regression model [Goldfarb-Rumyantzev AS, et al. 2003]. ANNs were 
used to predict the possibility of delayed graft function after deceased donor renal 
transplantation [Brier ME, et al. 2003]. For the development of our ANNs, we have opted to 
use a feed-forward with back-propagation model since it is known for its stability and 
tendency not to over fit [Ripley RM, et al. 2004]. The algorithm is often described as a 
decision making process functioning like the human brain [Cross SS, et al. 1995]. In 
statistical parlance, ANN models are a form of nonlinear discriminant analysis with input 
units, weights, and activation functions resembling covariates, coefficients, and generalized 
additive models, respectively. Thus, it is not surprising that ANN applications are 
undermined by similar limitations and misuses afflicting conventional discriminant 
analysis. Schwarzer identified four frequent mistakes when applying ANNs [Schwarzer et 
al., 2000]: 
• Overfitting models by training large, multilayer networks with small data sets. 
• Neglecting traditional statistical methods due to inadequate bench marks or lack of 
significance testing. 
• Applying naïve approaches to survival data, sometimes ignoring censorship. 
• Claiming overly optimistic generalization properties. 
In our study only significant univariate variables were incorporated as input units, but in 
multivariate cases, insignificant univariate variables sometimes become relevant 
confounders or effect modifiers. Since ANNs are touted as having the ability to select those 
items most important in performing classifications, this prior variable selection seems 
unnecessary [Figure 1].  
Our study was designed to predict 5-year survival using cases with complete data (81 with 
missing data were dropped) divided into training (n=1500) and test (n=319) sets for building 
and validating models, respectively. We followed steps to guard against these problems. To 
avoid over-fitting, the ANN was restricted to one hidden layer, and the number of hidden 
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nodes was controlled by reasonable stopping criteria. Also, the ratio of number of 
observations in the training set (1500) to number of parameters in the model (361) was 
greater than 2, a recommended guideline [Schwarzer et al., 2000] [Figure 2, 3]. 
 
 
Fig. 1. Artificial neural networks model construction for predicting graft survival. 
  
 
Fig. 2. Artificial neural networks architecture for predicting renal graft outcome. 
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Fig. 3. Validation strategy of transplantation Ann model. 
Preprocessing or normalizing data entering the ANN was done. This is an important step 
that usually requires a floating-point value between 0 and 1 to be assigned for each input 
node, with special consideration for missing values. The ANN model was tested against a 
nomogram built on a standard statistical approach (Cox regression) [Figure 4].  
 
 
Fig. 4. Cox based nomogram for predicting renal graft outcome. 
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Although this nomogram was simple to interpret by clinicians, but the linear nature of Cox 
regression may limit its handling power of complex tasks. The nomogram was not 
discarded altogether but credited for easy interpretation. The imputation strategy seemed to 
be sufficient since calibration points between average predicted (ANN) and observed 
(Kaplan-Meier) 5-year survival rates for various patient groups produced virtually a 45° 
line. The ANNs sensitivity was 88.43 (86.4 –90.3) %, specificity was 73.26 (70 –76.3) %, and 
its predictions was 16% significantly more accurate than the Cox regression-based 
nomogram (P<0.001). The Cox regression-based nomogram sensitivity was 61.84% (50 –72.8) 
with 74.9% (69–80.2) specificity and area under ROC curve was 72% (67–77) [Table 1].  
 
ANNs Nomogram  
0.88 0.72 Area under ROC curve 
0.77 0.40 Sensitivity at 95% specificity 
0.58 0.48 Sensitivity at 90 % specificity 
0.90 0.86 Specificity at 95% sensitivity 
0.48 0.30 Specificity at 90% sensitivity 
14.5 ( 0.1 ) 11.6   ( 0.2 ) 
Hosmer and lemeshow Test X2 
( P-value ) 
5 10 Prediction error % 
Table 1. Comparison of the predictive accuracy of renal graft survival between the Cox 
regression-based Nomogram and ANN. 
The predicted graft survival probabilities of both models responded well to the observed graft 
survival. The negative predictive value for the ANNs and Cox regression-based nomogram 
was 82% and 86.3%, respectively. Eighty-two percent of the ANNs predicted graft survival 
probabilities were responding to observed graft survival, whereas only 43.5% of the Cox 
regression-based nomogram predicted graft survival probabilities were responding to their 
observed graft survival. The predictive accuracy of the ANNs prognostic model was superior 
to that of the nomogram in predicting 5-year graft survival. In a future project, we shall 
implement the ANNs model that was developed in this study in a form of software to make it 
available to estimate survival and prognosticate individual transplant recipients outcomes. 
3. ANNs versus Nomograms and risk groups in cancer bladder: 
Radical cystectomy has evolved as the primary therapeutic modality for localized or regionally 
advanced invasive carcinoma of the bladder. Treatment outcomes after radical cystectomy 
have been based on TNM staging or pathological grouping [Ghoneim M, et al. 1997]. Although 
this prognostic grouping yielded useful estimates of recurrence risk and survival outcomes, 
significant variation within each group has been observed due to the heterogeneity of the 
tumor biology and patient characteristics. To circumvent these limitations several 
mathematically based prognostic models were developed which appear to outperform clinical 
judgment in estimating outcome probabilities. Accurate estimates of the likelihood of success, 
patient outcomes and long-term morbidity are essential for patient counseling, informed 
decision making and to assist in clinical trial design. Clinical judgment might be biased due to 
subjective and objective confounders that exist at all stages of the prediction process. The 
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clinical TNM staging system is routinely used in decision making and patient counseling. The 
ease of using this tool is offset by its limited accuracy. Additional factors that can provide a 
predictive value, e.g. age, gender, time to surgery and other pathological features such as 
lymphovascular invasion, are missed. The influence of tumor stage, grade and lymph node 
involvement has been investigated and extensively reported [Pollack A, et al. 1995]. To 
improve the accuracy of pathological staging molecular markers such as P53, P21, pRb, 
angiogenesis and growth factor changes have been identified as having potential  prognostic 
value [Ghoneim M, et al., 2008; Chatterjee SJ, et al., 2004]. It could be legitimately argued that 
the presence of a significant number of patients with bilharziasis may result in conclusions 
different from those of patients with cancer with typical nonbilharzial transitional cell cancer. 
However, on multivariate analysis the presence of bilharziasis was not an independent 
prognostic factor. Statistical methods based on logistic regression were traditionally used. 
Unfortunately complex interactions within medical data do not allow the easy use of these 
methods by clinicians. To overcome the shortcomings of conventional statistical methods, new 
models were developed to provide a means which incorporates multiple clinical, pathological 
properties into 1 system and achieves the best possible risk assessment. In our study the risk 
group stratification model identified 4 risk groups which were prospectively validated as in a 
previous work [Kiemeney LA, et al. 1993]. One of the potential advantages of such a system is 
the identification of a high risk group of patients for whom adjuvant therapy is indicated and 
justified [Ghoneim M, et al. 2000]. Another advantage of this model is its versatility. In the 
future additional prognostic variables that may influence survival significantly and 
independently could be included in the model once their regression estimate is determined. 
Construction of nomograms for survival prediction had been performed by several groups. 
The principle advantage of this approach is that it provides a survival probability for 
individual cases. Accordingly it could be maintained that they are more relevant to the patient 
than the group/level probabilities.  
In 2006 the IBCNC published the first postoperative nomogram predicting the risk of 
recurrence at 5 years after radical cystectomy [Stockle M, et al. 1995]. In the same year the 
BCRC reported their nomogram [Bochner B, et al. 2006]. The nomogram developed by the 
IBCNC had a predictive index of 75% while the BCRC nomogram offered a 4% accuracy 
advantage. It is clear that adding more variables would improve the accuracy of any 
prognostic model. Shariat et al demonstrated that an abnormal profile of 2 or more 
abnormal markers among a panel of 5 cell cycle regulator biomarkers increased the overall 
predictive accuracy of the nomogram from 72.6% to 83.4% [Shariat S, et al., 2006]. Both 
groups demonstrated that their nomograms were more accurate and discriminating than the 
TNM system, solving some of the heterogeneity of outcome prediction within each stage. 
Nevertheless these nomograms have inherent limitations. The extent of pelvic lymph node 
dissection and number of lymph nodes removed were not included, although these are 
reported as important prognostic indices [Herr HW, et al. 2004]. In our study the operative 
procedure was standardized and the pathological material was revised by a single 
pathologist. The positive predictive index was 82.9%, which is superior to that of previously 
mentioned studies. Artificial neural networks are complex computational systems that can 
perform a large number of mental tasks. They have many advantages compared to models 
based on logistic regression in that they do not require statistical training, they can deal with 
complex nonlinear relationships and detect possible interactions among predictor variables 
[Tu.JV, 1996]. In a recent investigation Bassi et al compared the prognostic accuracy of 
ANNs and logistic regression analysis for patients undergoing radical cystectomy [Bassi P, 
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et al. 2009]. They concluded that the ANNs accurately predicted survival and had a 
prognostic performance comparable to that of the logistic regression. In our study the 3 
models of risk group stratification, nomogram and ANNs were compared to assess accuracy 
and performance characteristics. 
4. Study layout 
Significant variables by multivariate analysis were used for building the risk group 
stratification model as well as for construction of the nomogram. On the other hand all the 
studied factors were entered directly into the ANNs [Figure 5, 6]. 
 
 
Fig. 5. Artificial neural networks model construction for predicting patient survival after 
radical cystectomy. 
 
 
Fig. 6. Artificial neural networks architecture for predicting patient survival after radical 
cystectomy. 
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5. Risk group stratification 
5.1 Model: construction and validation 
The regression coefficient (B) of the significant factors on multivariate analysis was used to 
construct the model for risk group stratification. The algebraic sum of the regression 
coefficients for each case represented a proportional hazard score (Y). The possible range of 
Y values of patients in the reference series was divided equally into 4 groups, whereby those 
with the lowest Y score represented the lowest risk category and those with the highest Y 
score the highest risk category. Survival curves were then constructed for each of the 4 
groups using the Kaplan-Meier method. Patients in the test series were classified into 4 
groups according to the previously mentioned proportional hazard score (Y). For external 
validation survival curves were constructed for each risk category of the test series and 
compared with the corresponding curves of the reference series. Statistical differences were 
determined using the log rank test with p <0.05 considered significant. In addition, the 
degree of discrimination was determined by computing the ROC curve [Figure 7]. 
 
 
Fig. 7. External validation of risk grouping for predicting patient survival after radical 
cystectomy. 
5.2 Nomogram: construction and validation 
For construction of the nomogram the R software package version 2.7.0 was used (R 
foundation for statistical computing, Bell Laboratories, Lucent technologies, with Frank 
Harrel’s Design and Hmisc libraries included). Each variable was assigned a scale of points 
according to prognostic significance which ranged from 0 to 100. The point values 
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determined for each individual case were added to give a total sum. The total sum thus 
calculated was correlated to the 5-year patient survival probability of the same case. 
Validation of the nomogram involved internal as well as external validation. Internal 
validation was performed by discrimination as well as calibration. The degree of 
discrimination was quantified by computation of the area under the ROC curve. The 
calibration was assessed by grouping patients with respect to nomogram predicted survival 
probabilities. The group means were then compared with the observed Kaplan-Meier 
estimates. For the discrimination and calibration steps a total of 200 bootstrap re-sampling 
was used to obtain less biased estimates. The test series was used for external validation. 
The degree of discrimination was again achieved by determination of the area under the 
ROC curve [Figure 8]. 
 
 
Fig. 8. Cox based nomogram for predicting patient survival after radical cystectomy. 
5.3 ANNs: Construction and validation 
All studied variables were used as input variables for ANN construction. The model used is 
commercially available software (SPSS version 16). The basis of this network is multilayer 
perceptrons that have feed-forward back-propagation topology. The network consists of 3 
layers.  
1. The input layer is of 31 neurons into which variables were entered following their 
normalization through a process process of standard rescaling (subtract the mean and 
divide by the standard deviation).  
2. A hidden layer is composed of 6 neurons in which computation and differential 
weighing of the different variables are performed.  
3. The output layer is 2 neurons into which the end results of therapy are entered (patient 
survival or loss).  
Training was performed by a conjugate gradient descent optimization algorithm. The target 
was to achieve a sum of squared error of 0.01. The model starts with 1 neuron in the hidden 
layer, and when that neuron fails to improve the square error at the end of the training cycle 
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another neuron is automatically added to the hidden layer to improve the model 
performance. This process is terminated once a sum of square error of 0.01 has been 
achieved or 1,000 training cycles are completed. Six neurons in the hidden layer and 200 
epochs (training cycles) were necessary to achieve this goal. After training the system was 
tested by internal and external validation using the same methodology as that used for the 
nomogram. 
6. Comparison of risk group 
Stratification, nomogram and ANNs 
The ability to discriminate between patient survival or loss using the 3 models was 
compared by estimation of the area under the ROC curves (MedCalc® software version 
9.3.7.0) Using these curves the sensitivity and specificity of the 3 models were also obtained 
at certain cutoff points. Comparisons between the performance and accuracy of the three 
models are provided in Figure 8 and Table 4. The ANNs outperformed the risk group 
stratification and nomogram models in predicting 5-year patient survival probabilities. 
ANNs were more sensitive and specific with a larger area under ROC curve than the other 
two models. The area under ROC curve for the ANNs was 0.86 while it was 0.72 for the risk 
groups and 0.74 for nomogram. Further more the ANNs demonstrated a superior positive 
as well as negative predictive values [Table 2].  
 
ANNs Nomogram 
Risk groups 
(A-D) 
 
0.86 (0.82-0.89) 0.74 (0.69-0.78) 0.72 (0.67-0.77) 
Area under ROC curve 
(95% CI)* 
78.7 (72.7-83.9) 60.44 (53.7 - 66.9) 61.06 (54.4 - 67.5) Sensitivity (95% CI)* 
81.25 (73.4-87.6) 78.46 (70.4 - 85.2) 75.38 (67.1 - 82.5) Specificity(95% CI)* 
4.20 2.81 2.48 Positive LR# 
0.26 0.50 0.52 Negative LR# 
87.9 82.9 81.2 Positive predictive value 
68.9 53.4 52.7 Negative predictive value 
13 ( 0.112 ) 10.7 (0.219) 0.16 (0.921) 
Hosmer and lemeshow Test 
X2 ( P-value ) 
Table 2.  Comparison of the predictive accuracy of patients survival following radical 
cystectomy between Risk groups, nomogram and ANNs.  
Predictive models for invasive bladder carcinoma can accurately stratify patients according 
to risk of recurrence, progression and treatment tolerability. This enables the clinicians to 
make the best decision in patient counseling, selecting the optimal adjuvant therapy and 
follow up schedule. Among the available models our comparative study provides evidence 
that ANNs have several advantages compared to risk groups and nomogram models, the 
most important being the higher predictive accuracy, better performance and clinical 
applicability. However, risk groups and nomograms rely on methodologically sound and 
valid alternatives that cannot be ignored. Despite their advantages predictive tools cannot 
replace clinical judgment. Their input has to be weighed against several other considerations 
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such as comorbidity, cost, and social and psychic factors. Finally improvements in the 
current models can be attained by incorporating modern imaging tools and novel 
biomarkers. Moreover validation in large patient cohorts and prospective data acquisition 
need no emphasis. 
7. Conclusions 
The Artificial neural networks outperformed the risk groups and nomogram models in 
predicting the 5-year patient survival. Furthermore, ANN have a more satisfactory 
prognostic performance in terms of specificity and sensitivity compared to the other models. 
8. References 
Akl A, Mostafa A, Ghoneim MA. (2008). Nomogram that predicts graft survival probability 
following living-donor kidney transplant. Exp Clin Transplant; 6: 30. 
Bassi P, Sacco E, DeMarco V, Aragona M, Volpe A. (2007). Prognostic accuracy of an 
artificial neural network in patients undergoing radical cystectomy for bladder 
cancer: a comparison with logistic regression analysis. BJU; 99 : 1007 – 12. 
Bochner B, Kattan M, Vora K. (2006). Postoperative nomogram predicting risk of recurrence 
after radical cystectomy for bladder cancer. J Clin Oncol; 24 (24): 3967 – 72. 
Brier ME, Ray PC, Klein JB. (2003). Prediction of delayed renal allograft function using an 
artificial neural network. Nephrol Dial Transplant; 18: 2655. 
Chatterjee SJ, Datar R, Youssefzadeh D, George B, Goebell PJ. (2004). Combined effects of 
p53, p21, and pRb expression in the progression of bladder transitional cell 
carcinoma. J Clin Oncol; 22 (6) : 1007 – 13. 
Cross SS, Harrison RF, Kennedy RL. (1995). Introduction to neural networks. Lancet; 346: 
1075. 
Djavan B, Remzi M, Zlotta A, et al. (2 002).Novel artificial neural network for early detection 
of prostate cancer. J Clin Oncol; 20: 921. 
Freeman RV, Eagle KA, Bates ER, et al. (2002). Comparison of artificial neural networks with 
logistic regression in prediction of in-hospital death after percutaneous 
transluminal coronary angioplasty. Am Heart J; 140: 511. 
Ghoneim M, Abdel-Latif M, El-Mekresh M, Abol-Enein H, Mosbah A. (2008). Radical 
cystectomy for carcinoma of the bladder: 2720 consecutive cases, 5 years later. J 
Urol; 180 : 121 – 7. 
Ghoneim M, El-Mekresh M, Mokhtar A, Gomha M, El-Baz M, El-Attar I.(2000). A predictive 
model of survival after radical cystectomy for carcinoma of the bladder. BJU; 85 : 
811 – 6. 
Ghoneim M, El-Mekresh M, El-Baz M, El-Attar I, Ashamallah A. (1997). Radical cystectomy 
for carcinoma of the bladder: critical evaluation of the results in 1026 cases. J Urol; 
158 : 393 – 9. 
Goldfarb-Rumyantzev AS, Scandling JD, Pappas L, et al. (2003). Prediction of 3-year 
cadaveric graft survival based on pre-transplant variables in a large national 
dataset. Clin Transplant;17: 485. 
Graefen BM, Karakiewicz PI, Cagiannos I, et al. (2002). Validation study of the accuracy of a 
postoperative nomogram for recurrence after radical prostatectomy for localized 
prostate cancer. J Clin Oncol; 20: 951. 
www.intechopen.com
 Artificial Neural Networks - Methodological Advances and Biomedical Applications 
 
342 
Grossberg JA, Reinert SE, Monaco AP, et al. (2006). Utility of a mathematical nomogram to 
predict delayed graft function: A single-center experience. Transplantation; 81: 155. 
Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, (2004). Surgical factors 
influence bladder cancer  outcomes. A cooperative group report. J Clin Oncol; 22 : 
2781 – 9. 
Kattan MW.(2005). When and how to use informatics tools in caring for urologic patients. 
Nat Clin Pract Urol; 2: 183. 
Kiemeney LA, Witjes JA, Verbeek AL, Heijbroek RP, Debruyne FM.(1993).  The clinical 
epidemiology of superficial bladder cancer. Dutch South-East cooperative 
urological group. B J Cancer ; 67 (4): 806 – 12. 
Poli F, Scalamogna M, Cardillo M, et al. (2000). An algorithm for cadaver kidney allocation 
based on a multivariate analysis of factors impacting on cadaver kidney graft 
survival and function. Transpl Int; 13(suppl 1): S259. 
Pollack A, Zagars G, Cole C, Dinney C, Swanson D, (1995). The relationship of local control 
to distant metastases in muscle invasive bladder cancer. J Urol; 154 : 2059 – 64. 
Ripley RM, Harris AL, Tarassenko L. (2004). Non-linear survival analysis using neural 
networks. Stat Med; 23: 825. 
Schwarzer G, Vach W, Schumacher M. (2000). On the misuses of artificial neural networks 
for prognostic and diagnostic classification in oncology. Stat Med; 19: 541. 
Shariat S, Karakiewicz P, Palapattu GS, Amiel GE, Lotan Y, et al. (2006). Nomograms 
provide improved accuracy for predicting survival after radical cystectomy. Clin 
Cancer Res; 12 : 6663 – 76. 
Stockle M, Meyenburg W, Wallek S, Voges GE, Rossmann M, et al. (1995). Gertenbach U, 
Thurof JW, Huber C, Hohenfellner R.  Adjuvant poly-chemotherapy of  non-organ-
confined bladder cancer after radical cystectomy. J Urol; 153 : 47-52. 
Tu.JV . (1996). Advantages and disadvantages of using artificial neural networks versus 
logistic regression for predicting medical outcomes. J Clin Epidemiol ; 49: 1225-31.    
Zapletal C, Lorenz MW, Woeste G, et al. (2004). Predicting creatinine clearance by a simple 
formula following live- donor kidney transplantation. Transpl Int; 17: 490. 
www.intechopen.com
Artificial Neural Networks - Methodological Advances and
Biomedical Applications
Edited by Prof. Kenji Suzuki
ISBN 978-953-307-243-2
Hard cover, 362 pages
Publisher InTech
Published online 11, April, 2011
Published in print edition April, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Artificial neural networks may probably be the single most successful technology in the last two decades which
has been widely used in a large variety of applications in various areas. The purpose of this book is to provide
recent advances of artificial neural networks in biomedical applications. The book begins with fundamentals of
artificial neural networks, which cover an introduction, design, and optimization. Advanced architectures for
biomedical applications, which offer improved performance and desirable properties, follow. Parts continue
with biological applications such as gene, plant biology, and stem cell, medical applications such as skin
diseases, sclerosis, anesthesia, and physiotherapy, and clinical and other applications such as clinical
outcome, telecare, and pre-med student failure prediction. Thus, this book will be a fundamental source of
recent advances and applications of artificial neural networks in biomedical areas. The target audience
includes professors and students in engineering and medical schools, researchers and engineers in
biomedical industries, medical doctors, and healthcare professionals.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ahmed Akl and Mohamed A Ghoneim (2011). Forcasting the Clinical Outcome: Artificial Neural Networks or
Multivariate Statistical Models?, Artificial Neural Networks - Methodological Advances and Biomedical
Applications, Prof. Kenji Suzuki (Ed.), ISBN: 978-953-307-243-2, InTech, Available from:
http://www.intechopen.com/books/artificial-neural-networks-methodological-advances-and-biomedical-
applications/forcasting-the-clinical-outcome-artificial-neural-networks-or-multivariate-statistical-models-
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
